The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
- 8 March 2021
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 191 (6), 1020-1035
- https://doi.org/10.1016/j.ajpath.2021.02.018
Abstract
No abstract availableKeywords
Funding Information
- BrightFocus Foundation
- National Eye Institute
- National Center for Advancing Translational Sciences
- Indiana University School of Medicine
This publication has 62 references indexed in Scilit:
- Existence of the Canonical Wnt Signaling Pathway in the Human Trabecular MeshworkInvestigative Ophthalmology & Visual Science, 2012
- Spliceosome Protein (SRp) Regulation of Glucocorticoid Receptor Isoforms and Glucocorticoid Response in Human Trabecular Meshwork CellsInvestigative Ophthalmology & Visual Science, 2012
- Steroid-Induced Iatrogenic GlaucomaOphthalmic Research, 2011
- Increased Intraocular Pressure in Mice Treated with DexamethasoneInvestigative Ophthalmology & Visual Science, 2010
- Myocilin Is a Modulator of Wnt SignalingMolecular and Cellular Biology, 2009
- Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressureJCI Insight, 2008
- Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor βExperimental Eye Research, 2007
- The Glucocorticoid Receptor Represses Cyclin D1 by Targeting the Tcf-β-Catenin ComplexOnline Journal of Public Health Informatics, 2006
- Glucocorticoids Inhibit the Transcriptional Activity of LEF/TCF in Differentiating Osteoblasts in a Glycogen Synthase Kinase-3β-dependent and -independent MannerOnline Journal of Public Health Informatics, 2005
- Preliminary characterization of a transformed cell strain derived from human trabecular meshworkCurrent Eye Research, 1994